Mono Pharmacare (NSE:MONOPHARMA) Total Tax Payable: ₹0 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MONOPHARMA Mono Pharmacare Ltd NSE:MONOPHARMA
22 GF Score
Price ₹8.95
! 6 Warning Signs
View Full Analysis

What is Mono Pharmacare Total Tax Payable?

Mono Pharmacare NSE:MONOPHARMA 22 Total Tax Payable is ₹0 Mil as of Sep. 2025. GuruFocus rates NSE:MONOPHARMA with a GF Score™ of 22/100. The stock has 6 warning signs investors should review.

Mono Pharmacare's Total Tax Payable for the quarter that ended in Sep. 2025 was ₹0 Mil.

Mono Pharmacare Total Tax Payable Related Terms

Mono Pharmacare Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Mono Pharmacare's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mono Pharmacare Total Tax Payable Chart

Mono Pharmacare Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Total Tax Payable
0.00 0.00 0.00 0.00 0.00

Mono Pharmacare Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Total Tax Payable Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:MONOPHARMA
22GF Score
Mono Pharmacare Ltd NSE:MONOPHARMA
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mono Pharmacare Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of ₹0 Mil mean?
Mono Pharmacare (NSE:MONOPHARMA) has a Total Tax Payable of ₹0 Mil as of Sep. 2025. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Mono Pharmacare and its competitors.
Is Mono Pharmacare's Total Tax Payable too high?
Mono Pharmacare's current Total Tax Payable is ₹0 Mil. Overall, Mono Pharmacare has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Mono Pharmacare's Total Tax Payable compare to competitors?
Mono Pharmacare's Total Tax Payable of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Healthcare Providers & Services company?
A good Total Tax Payable depends on the Healthcare Providers & Services industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Mono Pharmacare and its competitors. Mono Pharmacare's current Total Tax Payable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mono Pharmacare stock overvalued right now?
Mono Pharmacare (NSE:MONOPHARMA) has a current Total Tax Payable of ₹0 Mil. The current Total Tax Payable is ₹0 Mil. Mono Pharmacare's overall GF Score™ is 22/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Mono Pharmacare (NSE:MONOPHARMA), the current Total Tax Payable is ₹0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mono Pharmacare Business Description

Address 1A, Krinkal Apartment, Opposite Mahalaxmi Temple, Paldi, Ahmedabad, GJ, IND, 380007
Mono Pharmacare Ltd distributes a broad range of pharmaceutical products across India. Its portfolio includes antibiotics, antifungal medicines, cough and cold remedies, antacids, analgesics, nutraceuticals, skincare, antiseptics, cardiac and diabetic drugs, and cosmetic items. The company operates through contract manufacturing, sourcing products from various manufacturers and supplying them to healthcare providers and pharmacies. Revenue is generated through the sales and distribution of these pharmaceutical and healthcare products in the Indian market.
22GF Score

Get the complete analysis for NSE:MONOPHARMA

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8.95
Price